FINPIPEFinolex Industries Limited
Capital Goods · Building Products & Equipment · NSE · as of 2026-09-11 (delayed ~30 min in market hours)
Finolex Industries Limited manufactures and sells polyvinyl chloride (PVC) pipes and fittings, and PVC resins in India. It operates in two segments, PVC Resin and PVC Pipes and Fittings. The company offers agriculture pipes and fittings; column pipes; casing pipes; and solvent cement and lubricants. It also provides plumbing and sanitation pipes and fitting, such as ASTM pipes and fittings; CPVC pipes and fittings; SWR pipes and fittings; sewerage pipes; and solvent cement, lubricant, and primer. The company distributes its products through dealers and retailers. Finolex Industries Limited was founded in 1956 and is based in Pune, India.
Price & Volume
Loading chart…
Key Ratios
“—” means the figure isn't meaningful or isn't published for this company: ROE and Debt/Equity are undefined when shareholder equity is negative (check P/B — negative means negative equity), and DII/MF holding splits aren't provided by our current data source.
Active Pattern Signals
None of the 16 pattern scanners currently detects a setup on FINPIPE — signals appear here automatically when one forms (checked on every data refresh). The Trade Plan on the right always provides stop-loss and target levels regardless.
The picture
- • Profit growth: 59.0% YoY
- • Debt/Equity: 0.07
- • Promoter holding: 59.4%
- • Volatility: 27% annualized
- • Beta: 0.58
- • Liquidity: ₹7.5 cr avg turnover
Bull case
- • Profit growth: 59.0% YoY
- • Debt/Equity: 0.07
- • Promoter holding: 59.4%
- • Volatility: 27% annualized
Bear case
- • ROE: 9.7%
- • ROCE: 8.6%
- • RSI: 37
- • MACD: bearish
Key risks
- • Momentum is fading versus the broader market
- • ROE: 9.7%
- • ROCE: 8.6%
Algorithmic analysis for research only — not SEBI-registered investment advice.
Trade Plan
Stop = 20-day support with a 2.5×ATR risk cap (ATR ₹3.63). Levels recompute on every data refresh. Position sizing and execution are yours — this is analysis, not advice.